Literature DB >> 16738841

Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP).

Pieranna Fietta1, Paolo Manganelli.   

Abstract

Psoriatic onycho-pachydermo-periostitis (POPP)is a rare subset of psoriatic arthritis, characterized by onychopathy, painful thickening of the periungual soft tissues, and radiological features consisting of an exuberant periosteal reaction of the terminal phalanx. The POPP treatment is debated, and side effect risk of therapies may not be offset by their benefits. We report on a successful treatment with carnitine in a 15-year old boy suffering from POPP.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 16738841     DOI： 10.1007/s10067-006-0322-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  14 in total

1.  Psoriatic onycho-pachydermo-periostitis.

Authors:  J S Dosik
Journal:  Dermatol Online J       Date:  2001-02

2.  Psoriatic onycho-pachydermo periostitis: treatment with methotrexate.

Authors:  A Bauzá; P Redondo; D Aquerreta
Journal:  Br J Dermatol       Date:  2000-10       Impact factor: 9.302

3.  Severe nail dystrophy associated with painful fingertips. Diagnosis: psoriatic onychopachydermoperiostitis (POPP).

Authors:  C S Jury; C Fleming; D Kemmett
Journal:  Arch Dermatol       Date:  2000-07

4.  [Psoriatic onycho-pachydermo-periostitis of the big toe. Anatomo-clinical study and physiopathogenic approach apropos of 4 cases].

Authors:  B Fournié; R Viraben; R Durroux; S Lassoued; R Gay; A Fournié
Journal:  Rev Rhum Mal Osteoartic       Date:  1989 Jul-Sep

5.  Childhood onset of psoriatic onycho-pachydermo-periostitis (POPP).

Authors:  P Fietta; P Manganelli
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-11       Impact factor: 6.166

Review 6.  Psoriatic onycho-pachydermo-periostitis. A variant of psoriatic distal interphalangeal arthritis?

Authors:  A M Boisseau-Garsaud; M Beylot-Barry; M S Doutre; C Beylot; R Baran
Journal:  Arch Dermatol       Date:  1996-02

7.  Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab.

Authors:  T Bongartz; P Härle; S Friedrich; S Karrer; T Vogt; A Seitz; U Müller-Ladner
Journal:  Arthritis Rheum       Date:  2005-01

8.  [Psoriatic onycho-pachydermo-periostitis].

Authors:  M De Pontville; A Dompmartin; S De Raucourt; M Macro; B Rémond; D Leroy
Journal:  Ann Dermatol Venereol       Date:  1993       Impact factor: 0.777

9.  [Psoriatic onycho-pachydermo- periostitis].

Authors:  M M Kroiss; T Vogt; T Finkenzeller; M Landthaler; W Stolz
Journal:  Z Rheumatol       Date:  2002-10       Impact factor: 1.372

10.  Psoriatic onycho-periostitis. Report of three cases.

Authors:  P Goupille; J Laulan; V Védère; G Kaplan; J P Valat
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641
View more
  2 in total

Review 1.  Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment.

Authors:  Grigorios T Sakellariou; Ioannis Tsifountoudis; Periklis Vounotrypidis
Journal:  Clin Rheumatol       Date:  2021-04-08       Impact factor: 2.980

2.  Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis.

Authors:  Chao Chen; Guixue Hou; Chunwei Zeng; Yan Ren; Xiang Chen; Cong Peng
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.